Poland wants to increase drug production, reduce imports
19:51
Poland’s government has proposed changes to drug reimbursement rules that could reduce patient costs for medicines manufactured in Poland by up to 30%. The cabinet adopted the draft on October 27, and the measures are intended to take effect on January 1, 2027, subject to legislative approval. The proposal would prioritize applications for domestically produced medicines, ease administrative requirements and establish a national list of critical medicines.
The government aims to strengthen supply security: only 24% of 301 medicines considered critical are produced in Poland, and just 2% are made entirely domestically using Polish active ingredients. Polpharma plans to invest PLN 3.68 bln in developing and producing new drug technologies over the next five years.